Overview of Dr. Metts
Dr. Jonathan Metts is a pediatric hematologist/oncologist in Saint Petersburg, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Johns Hopkins All Children's Hospital. He received his medical degree from University of South Carolina School of Medicine and has been in practice 8 years. He is one of 49 doctors at Johns Hopkins All Children's Hospital and one of 5 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Pediatric Hematology & Oncology. He has more than 20 publications and over 100 citings.
Office
601 5th St S
Saint Petersburg, FL 33701Fax+1 727-767-4970
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- University of South Florida MorsaniResidency, Pediatrics, 2009 - 2012
- University of South Carolina School of MedicineClass of 2009
Certifications & Licensure
- FL State Medical License 2016 - 2027
- GA State Medical License 2013 - 2016
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors Start of enrollment: 2018 Aug 27
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
- A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue Start of enrollment: 2022 Nov 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02 - Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sapna Oberoi, Frank M Balis
Cancer. 2024-11-15 - Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib.Isaac Hauk, Ignacio Gonzalez-Gomes, Deepak Chellapandian, Jonathan Metts, Peter H Shaw
Pediatric Blood & Cancer. 2024-10-01
Press Mentions
- Researchers at Johns Hopkins All Children’s Seek to Adapt Adult Treatments to Fight Pediatric CancersSeptember 6th, 2019
- A Path of Scientific Inquiry Leads to St. PetersburgJuly 21st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: